Tecan appoints Martin Brusdeilins as Chief Scientific Officer and Member of the Group Management Board

07-11-2011: The Board of Directors of the Tecan Group has appointed Dr. Martin Brusdeilins as Chief Scientific Officer and a Member of the Group Management Board. He will head the new Science & Technology organizational unit at Group level and take up his role at Tecan on September 1, 2011.

Dr. Martin Brusdeilins has extensive experience in a variety of management positions in the diagnostic and life science industry. He worked at Ortho-Clinical Diagnostics Inc., an enterprise of the Johnson & Johnson Company in Rochester, New York, USA, from 2003 until the end of May 2011, latterly as Vice President Product Development. In this role and in his previous role as Vice President Research & Development, which he performed for over six years, he was responsible for global product development of all diagnostic instruments and reagents as well as the life cycle management of these products. From 1985 to 2003, Martin Brusdeilins held various management and professional positions at Roche Diagnostics in Europe and the USA, where he was responsible for the entire product development of near patient diagnostic tests and test instruments, including in his role as Vice President Research & Development Near Patient Testing. From 1998 to 2001, as Vice President and General Manager, he was responsible for production, research & development, marketing and quality assurance, and clinical studies in a business unit of Roche Diagnostics in the USA.

Martin Brusdeilins studied biochemistry at the Eberhard Karls Universität Tübingen and earned a doctorate in this subject at the Max Planck Institute for Biology in Tübingen, Germany. He is 59 years old and a German citizen.

The Science & Technology organizational unit was created as part of the new Group organization that became effective in 2011, with the aim of implementing Tecan's growth strategy even more effectively. The new structure aims to drive forward the development of integrated workflow solutions, to better leverage synergies in the development of technology, and to further accelerate the pace of innovation. Science & Technology bundles resources for the development of enabling technologies, for licensing, and for scouting of technologies. It is also responsible for evaluating the content of the technologies in M&A projects and for developing partnerships with industry and academic research. The organizational unit incorporates the Innovation & Incubation group, which will continue in its role.